Designing the Modern Health Stack | Alex Karnal
You likely have a 30-50% chance of a heart attack or stroke between ages 40-80, but medicines already exist that could reduce this risk below 10%. The same goes for diabetes, Alzheimer's, and addiction—we've cracked the code on most diseases that will claim our lives. The gap isn't needing more medi
1h 38mKey Takeaway
You likely have a 30-50% chance of a heart attack or stroke between ages 40-80, but medicines already exist that could reduce this risk below 10%. The same goes for diabetes, Alzheimer's, and addiction—we've cracked the code on most diseases that will claim our lives. The gap isn't needing more medicines; it's actually using the ones we have. Start by optimizing five defensive layers: lipid levels (LDL cholesterol), cardiometabolic health (glucose/visceral fat), neurocognitive health (amyloid plaques), inflammatory response, and blood pressure. Each layer has proven medicines available today.
Episode Overview
Alex Carnell, a leading biotech investor, discusses the current revolution in life sciences and how existing medicines could add a decade to our lives. He explains the concept of a 'health stack'—five defensive layers (lipids, cardiometabolic health, neurocognitive health, inflammation, and blood pressure) that can be proactively managed with available medicines. The conversation focuses heavily on GLP-1 medicines, their mechanisms, adoption patterns, and broader health impacts beyond weight loss.
Key Insights
The Trillion-Dollar Healthcare Revolution Is Here
2025 marks the most exciting year in biotech in two decades, not because of new discoveries, but because GLP-1 adoption proves people are ready to be proactive about health rather than reactive. This represents potential trillion-dollar reduction in annual healthcare spending through prevention rather than treatment. The gap between invention and impact is finally closing.
We've Already Solved Most Diseases—We Just Don't Use the Solutions
Scientists have already cracked the code on medicines that protect us from most diseases that claim our lives. Expected lifespan charts haven't budged in decades—not because we lack medicines, but because we aren't pointing existing medicines at the impact they can have. The first commercial proof that this is changing is the explosive adoption of GLP-1 medicines.
GLP-1s Do Far More Than Weight Loss
GLP-1 medicines provide cardiovascular protection independent of weight loss, reducing heart attack and stroke risk by over 20%. They also show a 94% reduction in progression from pre-diabetes to diabetes, reduce addiction to alcohol and drugs, lower inflammation, and protect kidneys. This single class of medicines addresses multiple layers of the health stack simultaneously.
People Want Tolerability Over Maximum Efficacy
Contrary to Wall Street's focus on maximum weight loss, patients prioritize medicines they can tolerate long-term at stable doses. Lower doses with fewer side effects drive higher adherence. The oral GLP-1 launched at 4x the rate of the most recent injectable, primarily due to $150/month pricing versus $500/month—proving price elasticity matters more than maximum efficacy.
Direct-to-Consumer Is Disrupting Traditional Medicine Distribution
More than half of new GLP-1 patients now bypass traditional doctor visits and get medicines directly through platforms like Lilly Direct. This represents a fundamental shift from capital-intensive sales rep models to consumer-driven healthcare. The compounded GLP-1 market (15-20% of total) proves people will take safety risks to access affordable preventive medicines.
Notable Quotes
"I would say that 2025 was probably the single most exciting year in my entire journey. What gets me fired up is that it's actually the first commercial proof that we are ready for what I think we're going to look back on in time as a once-in-a-lifetime trillion dollar revolution in all of public health."
"Incredible scientists have already cracked the code on most of the medicines we need to protect us from most of the diseases that will claim most of our lives. The gap is not necessarily needing more medicines. It's actually pointing those medicines at the impact that they can have."
"Most middle-aged men and women walking around have somewhere between a 30 and a 50% probability of having a heart attack and a stroke sometime between the time that they turn 40 and the time that they turn 80. And to me, that's tragic because we have the medicines that exist that can help us to dramatically lower that risk to sub 10%."
"We are seeing every week the oral version of WGOI is setting record after record after record. The most recent data that I looked at this past Friday says that that has now moved from 200,000 a week to 300,000 a week in just a few months time."
"I fundamentally believe there's no molecule that's more important than GLP1 across that entire axis. When we look across the five axes, the five layers of defense that are mission-critical for us maximizing the number of years that we can live and having the most life in those years."
Action Items
-
1
Assess Your Five Defensive Health Layers
Get tested for: LDL cholesterol levels, glucose/A1C and visceral fat, inflammatory markers (CRP), blood pressure, and cognitive baseline. Understanding where you stand on these five axes is the first step to building your personal health stack.
-
2
Consider Proactive Lipid Management
If you're middle-aged with elevated LDL cholesterol, discuss statins or PCSK9 inhibitors with your doctor. These medicines can reduce your 30-50% risk of heart attack/stroke to below 10%. Don't wait for a cardiac event to take action.
-
3
Explore Lower-Dose GLP-1 Options
If you're pre-diabetic or have visceral fat, research GLP-1 options at lower doses focused on tolerability rather than maximum weight loss. Look for direct-to-consumer options that may offer better pricing ($150-250/month vs $400-500/month).
-
4
Track Your Data Systematically Over Time
Build a system for monitoring and testing the offensive side of your health stack: nutrition quality, strength training frequency, sleep patterns, and biomarkers. Consistent tracking enables you to see trends and make data-driven adjustments before problems develop.